Skip to main content

TERUMO GLOBAL

Search

Select Region

Show — Select Region Hide — Select Region

- Regions/Countries
  - - Europe
    - Latin America
      - Mexico
        
        Brazil
        
        Colombia
        
        Chile and Argentina
        
        Latin America
  - - Asia Pacific
    - Australia
    - Korea
    - Vietnam
    - China
    - India
- Global Business website

About Terumo
About Terumo
Dear Stakeholders
Terumo Group Identity
Terumo Group Code of Conduct
Corporate Profile
Corporate Governance
Compliance
Procurement Activity
Regulations and Standards
Directors and Executive Officers
History
Our Stories
Terumo's Response to COVID-19
Business Overview
Business Overview
TIS Division (Terumo Interventional Systems)
Neurovascular Division (MicroVention)
Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
Vascular Graft Division (Terumo Aortic)
Hospital Care Solutions Division / Life Care Solutions Division
Pharmaceutical Solutions Division
Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
Sustainability
Sustainability
Sustainability News
Message from Top Management
Sustainability at the Terumo Group
Resolving Healthcare Challenges
Creating a Diverse and Inclusive Workplace
Reducing Environmental Footprint
Serving Our Communities
Report Library
GRI Standards Index
Technology
Technology
Basic Information
Basic Information Top
Research and Development
Production and Supply
Intellectual Property
Terumo Fellows
Stories - Our Technologies
Investors
Investors
Management Policy
Management Policy
Top Management Message
Business Risks
Disclaimer
IR Policy
Financial Highlights
IR Library
IR Library
Financial Statements
Presentations
Consolidated Financial Statements
Terumo Reports
IR Events
Shareholders & Stock
Shareholders Meeting
Stock Information
Shareholder Return
Credit Ratings and Corporate Bond
Analyst Coverage
Articles of Incorporation
Site Quote
IR Inquiries
News
News
May 25, 2022
Corporate
Terumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022
Corporate
Terumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022
Corporate
Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan
Adjunctive use of Blood Glucose Meter Principally Not Required
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Global Network
Global Network
Japan
North America
South America
Europe, Middle East and Africa
Greater China
Asia and Pacific

Breadcrumb

Home
News

News

Move to top

Top

Refining Searches

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

Corporate

Financial

December 21, 2012

Corporate

Terumo Corporation announced strategic alliance with ChineseAngioCare in Renal Denervation Technology for Hypertension Treatment (PDF 443.54 KB)
November 20, 2012

Corporate

Harvest Technologies Corporation Granted CE Mark for Expanded Clinical Indication for Treatment of No-Option Critical Limb Ischemia
October 05, 2012

Corporate

Terumo Determined a Site for Construction of New Factory in Vietnam

Investment in Expansion of the Blood Management Business
October 02, 2012

Corporate

Terumo Extends Licensing Agreement with Biosensors to Sell Nobori® DES System Incorporating BioMatrix™ Technology (PDF 72.47 KB)
August 28, 2012

Corporate

Terumo initiates clinical study to evaluate newly developed adhesion barrier product
August 23, 2012

Corporate

Terumo Joins the United Nations Global Compact
August 01, 2012

Corporate

Announcement regarding a Lawsuit for the Compensation of Damages against Olympus Corporation (PDF 10.76 KB)
July 26, 2012

Corporate

Notice on Today's Media Report (PDF 113.56 KB)
June 04, 2012

Corporate

Three-Year "NOBORI 2" Post Marketing Study Results Confirm Long-term Safety and Efficacy of Terumo's Nobori® Drug-Eluting Stent Positive Long-term Data from NOBORI 2 Presented at EuroPCR
May 23, 2012

Corporate

Terumo to Commence Sales of OFDI Intravascular Imaging System in Europe from July — Debuted at EuroPCR 2012, the World's Leading Cardiovascular Intervention Course —
May 10, 2012

Financial

Notice Regarding Dividend for the Fiscal Year Ended March 31, 2012
May 10, 2012

Corporate

Terumo Expands Production in AsiaNew Factory Established and Existing Facilities Expanded in Vietnam and the Philippines
May 07, 2012

Corporate

Terumo Corporation establishes new sales branch in Austria
April 02, 2012

Corporate

CaridianBCT and Terumo Transfusion Become Terumo BCT

Company Focuses on Commitment to Blood Banking, Transfusion Medicine and Cellular Therapies
March 27, 2012

Corporate

Terumo Establishes a Holding Company in Singapore
March 19, 2012

Corporate

Terumo Announces Strategic Business Alliance with Weigao in Peritoneal Dialysis Business
March 05, 2012

Corporate

NOBORI 2 study confirms efficacy and long-term safety of the Nobori® DES in daily practice
February 29, 2012

Corporate

Terumo Begins the World's First Clinical Study of Cardiac Regenerative Therapy Using Cell Sheets
February 27, 2012

Corporate

Regarding the Passing and Personnel Change of a Director
February 23, 2012

Corporate

Daiichi Sankyo and Terumo Announce Agreement for Co-development of Intradermal Vaccine for Infectious Disease
February 23, 2012

Financial

Terumo Corporation Announces Issuance of Unsecured Straight Bonds (PDF 61.58 KB)
January 19, 2012

Corporate

Terumo Corporation to Establish a New Production Factory in Yamaguchi Prefecture, Japan
January 16, 2012

Corporate

Terumo Americas Holding Acquires Onset Medical Corporation, A Leader In Innovative Sheath Technology Designed For Multiple, Minimally Invasive Clinical Applications

Pagination

Previous page
Current page1
Next page

Footer Menu

Show — Footer Menu Hide — Footer Menu

- Investors
- News
  - - News
    - Press Inquiries
- Global Network

About Terumo
Business Overview
Sustainability
Technology
Investors
News
Global Network

Footer

Show — Footer Hide — Footer

Terms and Conditions of Use
Privacy Policy
Cookie Policy
Cookie Settings
Social Media Policy
Site Map

Copyright © 2022 Terumo Corporation, All Rights Reserved.